Compare Stocks: GELS, AYTU, PLRZ, and UPC

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AYTU Aytu BioPharma	$2.05 +2.8%	$2.20	$1.80 ▼ $3.07	$22.23M	0.17	48,627 shs	320 shs
GELS Gelteq	$0.46 -4.2%	$0.60	$0.39 ▼ $2.01	$4.93M	-0.41	2.41 million shs	26,163 shs
PLRZ Polyrizon	$10.84 +11.3%	$10.91	$2.88 ▼ $18.20	$26.34M	-1.2	61,576 shs	31,675 shs
UPC Universe Pharmaceuticals	$4.23 -0.9%	$4.86	$2.00 ▼ $17.96	$21.24M	1.68	710,878 shs	113 shs

7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AYTU Aytu BioPharma	+1.02%	-2.93%	0.00%	-10.36%	-14.96%
GELS Gelteq	-2.06%	-16.36%	-31.42%	-9.42%	-64.17%
PLRZ Polyrizon	+7.62%	+0.72%	-11.70%	-25.48%	+37.57%
UPC Universe Pharmaceuticals	+3.39%	+1.43%	-2.06%	-12.86%	-28.83%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AYTU Aytu BioPharma	$2.05 +2.8%	$2.20	$1.80 ▼ $3.07	$22.23M	0.17	48,627 shs	320 shs
GELS Gelteq	$0.46 -4.2%	$0.60	$0.39 ▼ $2.01	$4.93M	-0.41	2.41 million shs	26,163 shs
PLRZ Polyrizon	$10.84 +11.3%	$10.91	$2.88 ▼ $18.20	$26.34M	-1.2	61,576 shs	31,675 shs
UPC Universe Pharmaceuticals	$4.23 -0.9%	$4.86	$2.00 ▼ $17.96	$21.24M	1.68	710,878 shs	113 shs

7 Stocks That Could Lead the Next Market Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AYTU Aytu BioPharma	+1.02%	-2.93%	0.00%	-10.36%	-14.96%
GELS Gelteq	-2.06%	-16.36%	-31.42%	-9.42%	-64.17%
PLRZ Polyrizon	+7.62%	+0.72%	-11.70%	-25.48%	+37.57%
UPC Universe Pharmaceuticals	+3.39%	+1.43%	-2.06%	-12.86%	-28.83%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AYTU Aytu BioPharma	2.00	Hold	$14.50	609.05% Upside
GELS Gelteq	1.00	Sell	N/A	N/A
PLRZ Polyrizon	1.00	Sell	N/A	N/A
UPC Universe Pharmaceuticals	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest GELS, AYTU, PLRZ, and UPC Analyst Ratings

Date	Company	Brokerage	Action	Rating
10/8/2026	PLRZ Polyrizon	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
10/6/2026	AYTU Aytu BioPharma	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D) ➝ Sell (D-)
10/5/2026	AYTU Aytu BioPharma	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Hold ➝ Strong Sell
9/22/2026	AYTU Aytu BioPharma	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Positive
9/22/2026	AYTU Aytu BioPharma	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (D-) ➝ Sell (D)
9/22/2026	GELS Gelteq	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (E+)
9/18/2026	PLRZ Polyrizon	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
9/1/2026	PLRZ Polyrizon	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
8/14/2026	PLRZ Polyrizon	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
8/13/2026	AYTU Aytu BioPharma	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Strong Sell ➝ Hold
7/29/2026	PLRZ Polyrizon	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)

(Data available from 10/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AYTU Aytu BioPharma	$57.57M	0.39	N/A	N/A	$3.29 per share	0.62
GELS Gelteq	$110K	44.79	N/A	N/A	$1.08 per share	0.43
PLRZ Polyrizon	N/A	N/A	N/A	N/A	$13.05 per share	N/A
UPC Universe Pharmaceuticals	$17.86M	1.19	N/A	N/A	$99.64 per share	0.04

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AYTU Aytu BioPharma	-$14.25M	-$1.66	N/A	14.61	N/A	-24.76%	-56.54%	-13.14%	11/12/2026 (Estimated)
GELS Gelteq	-$4.30M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PLRZ Polyrizon	-$3.34M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
UPC Universe Pharmaceuticals	-$3.67M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest GELS, AYTU, PLRZ, and UPC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
9/28/2026	Q2 2026	PLRZ Polyrizon	N/A	-$0.3950	N/A	-$0.3950	N/A	N/A
7/29/2026	Q2 2026	UPC Universe Pharmaceuticals	N/A	-$1.38	N/A	-$1.38	N/A	$4.52 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AYTU Aytu BioPharma	N/A	N/A	N/A	N/A	N/A
GELS Gelteq	N/A	N/A	N/A	N/A	N/A
PLRZ Polyrizon	N/A	N/A	N/A	N/A	N/A
UPC Universe Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AYTU Aytu BioPharma	0.26	1.13	1.00
GELS Gelteq	N/A	N/A	N/A
PLRZ Polyrizon	N/A	36.37	N/A
UPC Universe Pharmaceuticals	0.04	4.05	3.90

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AYTU Aytu BioPharma	33.49%
GELS Gelteq	N/A
PLRZ Polyrizon	N/A
UPC Universe Pharmaceuticals	0.18%

Insider Ownership

Company	Insider Ownership
AYTU Aytu BioPharma	4.90%
GELS Gelteq	N/A
PLRZ Polyrizon	N/A
UPC Universe Pharmaceuticals	57.38%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AYTU Aytu BioPharma	83	10.87 million	10.34 million	Not Optionable
GELS Gelteq	18	10.71 million	N/A	N/A
PLRZ Polyrizon	1	2.43 million	N/A	N/A
UPC Universe Pharmaceuticals	216	5.02 million	2.14 million	N/A

GELS, AYTU, PLRZ, and UPC Headlines

Recent News About These Companies

Law Offices of Howard G. Smith Announces Investigation of Universe Pharmaceuticals INC. (UPC) on Behalf of Investors

October 12 at 12:02 PM | financialcontent.comF

Law Offices of Howard G. Smith Announces Investigation of Universe Pharmaceuticals INC.

October 12 at 10:00 AM | businesswire.com

Universe Pharmaceuticals 2026 AGM: Shareholders Approve All Eight Proposals Including Conditional Share Consolidation

October 8, 2026 | kalkinemedia.comK

The Law Offices of Frank R. Cruz Announces Investigation of Universe Pharmaceuticals INC. (UPC) on Behalf of Investors

October 7, 2026 | tmcnet.com

The Law Offices of Frank R. Cruz Announces Investigation of Universe Pharmaceuticals INC.

October 7, 2026 | businesswire.com

Universe Pharmaceuticals shares rise 22.6% premarket with no new catalyst identified

September 2, 2026 | msn.com

Universe Pharmaceuticals (UPC) stock soars over 38% after-hours: Here's what's going on

September 2, 2026 | msn.com

Universe Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:UPC

July 18, 2026 | benzinga.com

Universe Pharmaceuticals INC - Ordinary Shares - Class A

July 17, 2026 | money.usnews.com

Universe Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:UPC | Benzinga

June 29, 2026 | benzinga.com

4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones

June 29, 2026 | markets.businessinsider.com

China's Universe Pharmaceuticals (NASDAQ: UPC) Makes Nasdaq Top Gainer List on Acquisition News

June 29, 2026 | investorideas.comI

Universe Pharmaceuticals INC.: Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio

June 27, 2026 | finanznachrichten.de

Universe Pharmaceuticals Inc

June 26, 2026 | fool.com

UPC stock surges 288% after hours — what’s driving the rally?

June 26, 2026 | msn.com

Universe Pharmaceuticals to acquire Best Praise for $10.75M

June 26, 2026 | seekingalpha.com

Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio

June 26, 2026 | globenewswire.com

Universe Pharmaceuticals Stock News

June 17, 2026 | benzinga.com

Hologic Secures Significant Patent Victory Against Siemens Over Breast Cancer Detection Technology

June 16, 2026 | businesswire.com

Universe Pharmaceuticals Incorporation Class A

April 29, 2026 | edition.cnn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

GELS, AYTU, PLRZ, and UPC Company Descriptions

Aytu BioPharma NASDAQ:AYTU

$2.04 +0.06 (+2.76%)

As of 10:29 AM Eastern

Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.

Gelteq NASDAQ:GELS

$0.46 -0.02 (-4.19%)

As of 10:36 AM Eastern

Gelteq Inc. is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition. Gelteq Inc. is based in NEW YORK.

Polyrizon NASDAQ:PLRZ

$10.84 +1.10 (+11.29%)

As of 10:35 AM Eastern

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.

Universe Pharmaceuticals NASDAQ:UPC

$4.23 -0.04 (-0.94%)

As of 10:32 AM Eastern

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest GELS, AYTU, PLRZ, and UPC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest GELS, AYTU, PLRZ, and UPC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

GELS, AYTU, PLRZ, and UPC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

GELS, AYTU, PLRZ, and UPC Company Descriptions

Aytu BioPharma NASDAQ:AYTU

Gelteq NASDAQ:GELS

Polyrizon NASDAQ:PLRZ

Universe Pharmaceuticals NASDAQ:UPC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest GELS, AYTU, PLRZ, and UPC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest GELS, AYTU, PLRZ, and UPC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

GELS, AYTU, PLRZ, and UPC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

GELS, AYTU, PLRZ, and UPC Company Descriptions

Aytu BioPharma NASDAQ:AYTU

Gelteq NASDAQ:GELS

Polyrizon NASDAQ:PLRZ

Universe Pharmaceuticals NASDAQ:UPC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools